Literature DB >> 18706843

Patient non-adherence and healthcare-provider inertia are clinical myopia.

G Reach1.   

Abstract

The efficient implementation of healthcare is often jeopardized by the lack of patient adherence to medical recommendations and by inadequate healthcare-provider adherence to current guidelines, a phenomenon recently described as "clinical inertia". We propose here a theoretical model, based on concepts developed in the field of analytical philosophy of mind, that describes the mental mechanisms shared by the two phenomena, thus explaining their synergistically deleterious influence on the efficiency of care. We suggest that a failure to give preference to the long-term benefits of treatment intensification may represent a common mechanism underlying both patient non-adherence and physician clinical inertia. We dub such a failure as "clinical myopia". The model is explained in the context of clinical observations made in type 1 and 2 diabetic patients. However, it may also be relevant to other asymptomatic chronic diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18706843     DOI: 10.1016/j.diabet.2008.02.008

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  11 in total

Review 1.  Blood glucose pattern management in diabetes: creating order from disorder.

Authors:  Pratik Choudhary; Stefano Genovese; Gérard Reach
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

2.  Can technology improve adherence to long-term therapies?

Authors:  Gérard Reach
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

3.  Diabetes, Therapeutic Inertia, and Patients' Medication Experience.

Authors:  Andrew S Bzowyckyj; John E Begert
Journal:  Diabetes Spectr       Date:  2020-02

4.  Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.

Authors:  Nicolas Girerd; Jean-Jacques Von Hunolstein; Pierpaolo Pellicori; Antoni Bayés-Genís; Tiny Jaarsma; Lars H Lund; Pascal Bilbault; Jean-Marc Boivin; Tahar Chouihed; Jérôme Costa; Jean-Christophe Eicher; Estelle Fall; David Kenizou; Bruno Maillier; Pierre Nazeyrollas; Gérald Roul; Noura Zannad; Patrick Rossignol; Marie-France Seronde
Journal:  ESC Heart Fail       Date:  2022-04-15

Review 5.  The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review.

Authors:  Jean-Pierre Lebeau; Jean-Sébastien Cadwallader; Isabelle Aubin-Auger; Alain Mercier; Thomas Pasquet; Emmanuel Rusch; Kristin Hendrickx; Etienne Vermeire
Journal:  BMC Fam Pract       Date:  2014-07-02       Impact factor: 2.497

6.  Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Authors:  Sanjay Kalra; Ambrish Mithal; Rakesh Sahay; Mathew John; A G Unnikrishnan; Banshi Saboo; Sujoy Ghosh; Debmalya Sanyal; Laurence J Hirsch; Vandita Gupta; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2017-03-13       Impact factor: 2.945

7.  Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.

Authors:  Lawrence Blonde; Denis Raccah; Elisheva Lew; Juliana Meyers; Elena Nikonova; Mayank Ajmera; Keith L Davis; Monica Bertolini; Bruno Guerci
Journal:  Diabetes Ther       Date:  2018-04-19       Impact factor: 2.945

8.  Patient perceptions of their glycemic control and its influence on type 2 diabetes outcomes: an international survey of online communities.

Authors:  Kristina Simacek; Christopher Curran; Peter Fenici; Ricardo Garcia-Sanchez
Journal:  Patient Prefer Adherence       Date:  2019-02-18       Impact factor: 2.711

Review 9.  Changing the treatment paradigm for type 2 diabetes.

Authors:  Stefano Del Prato; Giuseppe Penno; Roberto Miccoli
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care.

Authors:  Gustavo Saposnik; Philippe N Tobler; Fernando Caceres; Maria A Terzaghi; Christian Ruff; Jorge Maurino; Manuel Fruns Quintana; Jiwon Oh; Xavier Montalban; Muhammad Mamdani
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.